T1	Intervention 565 650	The HbA1c level and maternal-fetal outcome were evaluated in both the treatment group
T2	Intervention 263 356	continuous subcutaneous insulin infusion (CSII) or multiple daily injections of insulin (MDI)
T3	Intervention 652 909	Outcome parameters such as glycemic control (HbA1c), hypoglycemic events, time and mode of delivery and labor results (abortion, premature labor, perinatal mortality, neonatal weight, Apgar score, neonatal hypoglycaemia, presence of congenital abnormalities
